gliclazide and resveratrol

gliclazide has been researched along with resveratrol in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM1
Palsamy, P; Subramanian, S1
Palsamy, P; Sivakumar, S; Subramanian, S1
Bilgin, HM; Deniz Obay, B; Elbey, B; Şermet, A; Taşdemir, E; Yazgan, ÜC1
Aktaş, A; Atamer, Y; Deveci, E; Ezel, T; Kocyigit, Y; Sermet, A; Uysal, E; Yavuz, D1

Other Studies

5 other study(ies) available for gliclazide and resveratrol

ArticleYear
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
    Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship

2008
Modulatory effects of resveratrol on attenuating the key enzymes activities of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats.
    Chemico-biological interactions, 2009, May-15, Volume: 179, Issue:2-3

    Topics: Administration, Oral; Animals; Carbohydrate Metabolism; Diabetes Mellitus, Experimental; Disease Models, Animal; Drug Evaluation, Preclinical; Fructose-Bisphosphatase; Gliclazide; Glucose-6-Phosphatase; Glucosephosphate Dehydrogenase; Glycogen Phosphorylase; Glycogen Synthase; Hexokinase; Hypoglycemic Agents; Kidney; L-Lactate Dehydrogenase; Liver; Male; Niacinamide; Pyruvate Kinase; Rats; Rats, Wistar; Resveratrol; Stilbenes; Streptozocin

2009
Resveratrol attenuates hyperglycemia-mediated oxidative stress, proinflammatory cytokines and protects hepatocytes ultrastructure in streptozotocin-nicotinamide-induced experimental diabetic rats.
    Chemico-biological interactions, 2010, Jul-30, Volume: 186, Issue:2

    Topics: Animals; Antioxidants; Cytokines; Diabetes Mellitus, Experimental; Gliclazide; Hepatocytes; Hyperglycemia; Hypoglycemic Agents; Inflammation Mediators; Male; Microscopy, Electron, Transmission; Models, Biological; Niacinamide; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Stilbenes

2010
Comparison of the anti-diabetic effects of resveratrol, gliclazide and losartan in streptozotocin-induced experimental diabetes.
    Archives of physiology and biochemistry, 2015, Volume: 121, Issue:4

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Gliclazide; Glycated Hemoglobin; Hypoglycemic Agents; Losartan; Male; Rats; Rats, Wistar; Resveratrol; Stilbenes

2015
Biochemical and Histopathological Investigation of Resveratrol, Gliclazide, and Losartan Protective Effects on Renal Damage in a Diabetic Rat Model.
    Analytical and quantitative cytopathology and histopathology, 2015, Volume: 37, Issue:3

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Gliclazide; Hypoglycemic Agents; Immunohistochemistry; Kidney; Losartan; Male; Rats; Rats, Wistar; Resveratrol; Stilbenes

2015